Compare VYX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYX | QDEL |
|---|---|---|
| Founded | 1881 | 1979 |
| Country | United States | United States |
| Employees | 13500 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.9M | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | VYX | QDEL |
|---|---|---|
| Price | $6.52 | $11.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $13.67 | ★ $28.25 |
| AVG Volume (30 Days) | 2.2M | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.02 | $9.92 |
| 52 Week High | $14.67 | $35.58 |
| Indicator | VYX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 47.70 |
| Support Level | $6.21 | $10.39 |
| Resistance Level | $7.26 | $12.85 |
| Average True Range (ATR) | 0.42 | 0.95 |
| MACD | -0.12 | 0.34 |
| Stochastic Oscillator | 12.78 | 70.14 |
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.